from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3658c/-

LFCtreatmentdescriptionclass of inhibitor

0.172

Amikacinug/mL Amikacintranslation

0.169

Cap5-10ug/mL Capreomycintranslation

0.678

Rox10-50 ug/mL Roxithromycintranslation

0.692

SM2-5 ug/mL Streptomycintranslation

2.023

Tet5-10 ug/mL Tetracyclinetranslation

0.833

Rif0.2-5ug/mL Rifampicintranscription

0.050

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.375

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.991

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.409

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.642

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.011

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.109

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.392

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.383

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-1.606

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.000

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-1.288

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.416

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-1.184

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.977

KCN5-20 ug/mL Potassium cyaniderespiration

0.000

NaN30.2-2 mM Sodium aziderespiration

-1.152

Nigericin50 uM Nigericinrespiration

-0.022

TRC10-150 ug/mL Triclosanrespiration

0.358

TRZ10-25 ug/mL Thioridazinerespiration

2.487

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

-1.288

menadione6-10 ug/mL Menadionerespiration

0.103

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-1.292

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.223

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.958

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

1.031

NRP_1Non-replicating persistence stage 1dosRassociated

0.804

Amp0.2mg/mL AmpicillincellWall

-0.305

Cephalexin20-100 ug/mL CephalexincellWall

0.583

Cerulenin0.32-5 ug/mL CerulenincellWall

0.144

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.137

EMB10-20 ug/mL EthambutolcellWall

0.228

Eta12-40 ug/mL EthionamidecellWall

-0.337

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.189

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.051

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.178

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.274

BZA0.12 mg/mL BenzamidearomaticAmides

0.380

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.229

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.418

H2O24 mM hydrogen peroxideDNAdamaging

0.074

Levo10 ug/mL LevofloxacinDNAdamaging

-0.153

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.234

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.030

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.017

UVUV-irradiationDNAdamaging

0.154

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.972

Antimycin12.5-50 ug/mL Antimycin A?

-1.100

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.286

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.042

PA_2110-50 ug/mL Antitubercular compound PA-21?

0.172

PA8240.2-2 ug/mL PA-824?

-0.086

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.073

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-1.008

Verapamil50 uM Verapamil?

-0.748

mercaptoethanol2 mM 2-Mercaptoethanol?

0.133

methoxatin10-20 ug/mL Methoxatin?